日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Developing the Creative Abilities of Children with Learning Differences in Rural, Low-Resource Settings in Africa: A Case Series Study

在非洲农村资源匮乏地区培养学习障碍儿童的创造力:案例研究

Conolly, Naomi Beth; Hoosain, Munira; McDonald, Doranne; van der Walt, Janke; Plastow, Nicola Ann

Handling missing values in patient-reported outcome data in the presence of intercurrent events

处理存在并发事件时患者报告结局数据中的缺失值

Thomassen, Doranne; Roychoudhury, Satrajit; Amdal, Cecilie Delphin; Reynders, Dries; Musoro, Jammbe Z; Sauerbrei, Willi; Goetghebeur, Els; le Cessie, Saskia

Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn's Disease: Individual Participant Data Meta-Analysis of 309 Patients from 12 Studies

克罗恩病肛周瘘管患者停用抗肿瘤坏死因子治疗:来自 12 项研究的 309 例患者的个体参与者数据荟萃分析

Ten Bokkel Huinink, Sebastiaan; Thomassen, Doranne; Steyerberg, Ewout W; Pauwels, Renske W M; Casanova, Maria J; Bouguen, Guillaume; Mak, Joyce W Y; Molnár, Tamas; Lobo, Alan J; Seidelin, Jacob B; Amiot, Aurelien; D'Haens, Geert; Rivière, Pauline; Guidi, Luisa; Bor, Renata; Lin, Wei-Chen; Peyrin-Biroulet, Laurent; Gisbert, Javier P; Janneke van der Woude, C; de Vries, Annemarie C

The role of the estimand framework in the analysis of patient-reported outcomes in single-arm trials: a case study in oncology

估计量框架在单臂试验患者报告结局分析中的作用:以肿瘤学为例

Thomassen, Doranne; Roychoudhury, Satrajit; Amdal, Cecilie Delphin; Reynders, Dries; Musoro, Jammbe Z; Sauerbrei, Willi; Goetghebeur, Els; le Cessie, Saskia

A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages

托珠单抗和沙利珠单抗不同剂量治疗重症COVID-19疗效的比较:药物短缺导致的自然实验

Swets, Maaike C; Moss, Rob J; Kor, Flip; Hilarius, Doranne; Moes, Dirk Jan A R; Berkhout, Willemijn Em; van den Toorn, Leon M; van den Oever, Niels C Gritters; de Valk, Renee; Rosendaal, Frits R; Hunfeld, Nicole; Groeneveld, Geert H; de Boer, Mark G J

Pulmonary Specialist-Supported Health Coaching Delivered by Lay Personnel Improves Receipt of Quality Care for Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial

由肺科专家支持、非专业人员提供的健康指导可提高慢性阻塞性肺病患者获得高质量护理的几率:一项随机对照试验

Willard-Grace, Rachel; Hessler, Danielle; Huang, Beatrice; DeVore, Denise; Chirinos, Chris; Wolf, Jessica; Low, Devon; Garvey, Chris; Donesky, DorAnne; Tsao, Stephanie; Thom, David H; Su, George

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF(V600)-mutant advanced melanoma patients: a propensity-matched survival analysis

更正:BRAF/MEK抑制剂一线治疗与抗PD-1单药治疗BRAF(V600)突变型晚期黑色素瘤患者的倾向性匹配生存分析

van Breeschoten, Jesper; Wouters, Michel W J M; Hilarius, Doranne L; Haanen, John B; Blank, Christian U; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; de Groot, Jan-Willem B; Hospers, Geke A P; Kapiteijn, Ellen; Piersma, Djura; van Rijn, Roos S; Suijkerbuijk, Karijn P M; Blokx, Willeke A M; Tije, Bert-Jan J Ten; Veldt, Astrid A M van der; Vreugdenhil, Art; Boers-Sonderen, Marye J; van den Eertwegh, Alfonsus J M

Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis

荷兰临床审计研究所药物项目对药物使用和临床结果的定量分析

Ismail, Rawa Kamaran; van Breeschoten, Jesper; van der Flier, Silvia; van Loosen, Caspar; Pasmooij, Anna Maria Gerdina; van Dartel, Maaike; van den Eertwegh, Alfons; de Boer, Anthonius; Wouters, Michel; Hilarius, Doranne

The unfavorable effects of COVID-19 on Dutch advanced melanoma care

新冠疫情对荷兰晚期黑色素瘤治疗的不利影响

van Not, Olivier J; van Breeschoten, Jesper; van den Eertwegh, Alfonsus J M; Hilarius, Doranne L; De Meza, Melissa M; Haanen, John B; Blank, Christian U; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; de Groot, Jan Willem B; Hospers, Geke A P; Ismail, Rawa K; Kapiteijn, Ellen; Piersma, Djura; van Rijn, Rozemarijn S; Stevense-den Boer, Marion A M; van der Veldt, Astrid A M; Vreugdenhil, Gerard; Boers-Sonderen, Marye J; Blokx, Willeke A M; Suijkerbuijk, Karijn P M; Wouters, Michel W J M

Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors

接受 BRAF-MEK 抑制剂治疗的晚期黑色素瘤患者的长期生存率

Ismail, Rawa K; Suijkerbuijk, Karijn P M; de Boer, Anthonius; van Dartel, Maaike; Hilarius, Doranne L; Pasmooij, A M G; van Zeijl, Michiel C T; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; Blank, Christian U; Boers-Sonderen, Marye J; de Groot, Jan W B; Haanen, John B A G; Hospers, Geke A P; Kapiteijn, Ellen; Piersma, Djura; van Rijn, Rozemarijn S; van der Veldt, Astrid A M; Vreugdenhil, Art; Westgeest, Hans; van den Eertwegh, Alfons J; Wouters, Michel W J M